Hyperammonaemic encephalopathy due to valproic acid in the neonatal period;Encefalopatía hiperamoniémica inducida por ácido valproico en período neonatal

Revista de Neurologia

Volumn 48, Issue 11, 2009, Pages 613-614

  Jiménez Parrilla, Francisco ^a   Perez Sanchez A ^a   Nunez Solis J M ^a   Madruga Garrido, M ^a   Losada Martinez A ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

VALPROIC ACID; ANTICONVULSIVE AGENT;

APGAR SCORE; BRAIN DISEASE; HUMAN; LETTER; NEWBORN CARE; CASE REPORT; CHEMICALLY INDUCED DISORDER; HYPERAMMONEMIA; METABOLIC ENCEPHALOPATHY; NEWBORN; SEIZURE;

ANTICONVULSANTS; BRAIN DISEASES, METABOLIC; HUMANS; HYPERAMMONEMIA; INFANT, NEWBORN; SEIZURES; VALPROIC ACID;

EID: 68849115377     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4811.2008627     Document Type: Letter

References (22)

1. Kay JD, Hilton-Jones D, Hyman N. Valproate toxicity and ornithine carbamoyltransferase deficiency. Lancet 1986; 2: 1283-1284 (Pubitemid 17182873)
2. Hawkes ND, Thomas GA, Jurewicz A, Williams OM, Hillier CE, McQueen IN, et al. Non-hepatic hyperammonaemia: an important, potentially reversible cause of encephalopathy. Postgrad Med J 2001; 77: 717-722 (Pubitemid 33016073)
3. Kwan P, Brodie MJ. Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 2001; 357: 216-222 (Pubitemid 32108114)
4. Ricard C, Martin K, Tournier M, Begaud B, Verdoux H. A case of Parkinsonian syndrome, cognitive impairment and hyperammonemia induced by divalproate sodium prescribed for bipolar disorder. Encephale 2005; 31: 98-101. (Pubitemid 40459925)
5. Verrotti A, Trotta D, Morgese G, Chiarelli F. Valproate-induced hyperammonemic encephalopathy. Metab Brain Dis 2002; 17: 367-373
6. Laub MC. Hyperammonemia in valproate therapy in children and adolescents. Nervenarzt 1986; 57: 314-318
7. O'Neil M, Dubrey RW, Grocott-Mason RM. Valproate encephalopathy and hyperammonaemia. Postgrad Med J 2002; 78: 316-317
8. Hamer HM, Knake S, Schomburg U, Rosenow F. Valproate-induced hyperammonemic encephalopathy in the presence of topiramate. Neurology 2000; 54: 230-232 (Pubitemid 30038768)
9. Gal P, Oles KS, Gilman JT, Weaver R. Valproic acid efficacy, toxicity, and pharmacokinetics in neonates with intractable seizures. Neurology 1988; 38: 467-471 (Pubitemid 18083690)
10. Unal E, Kaya U, Aydin K. Fatal valproate overdose in a newborn baby. Hum Exp Toxicol 2007; 26: 453-456 (Pubitemid 47057005)
11. Chen WT, Yen DJ, Yu HY, Liao KK. Valproate-induced encephalopathy. Chin Med J 2001; 64: 474-478
12. Altunbasak S, Baytok V, Tasouji M, Herguner O, Burgut R, Kayrin L. Asymptomatic hyperammonemia in children treated with valproic acid. J Child Neurol 1997; 12: 461-463 (Pubitemid 28023537)
13. Verrotti A, Greco R, Morgese G, Chiarelli F. Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs. Int J Clin Lab Res 1999; 29: 36-40. (Pubitemid 29243233)
14. Durán-Ferreras E, Jiménez-Vilches PL, Galán-Barranco JM, Fernández-Bolaños Porras R. Encefalopatía hiperamoniémica por ácido valproico. Rev Neurol 2008; 46: 537-539
15. Laub MC, Paetzke-Brunner I. Serum carnitine during valproic acid therapy. Epilepsia 1986; 27: 559-562 (Pubitemid 16026053)
16. Ohtani Y, Endo F, Matsuda I. Carnitine deficiency and hyperammonemia associated with valproic acid therapy. J Pediatr 1982; 101: 782-785
17. Gidal BE, Inglese CM, Meyer JF, Pitterle ME, Antonopolous J, Rust RS. Diet-and valproate-induced transient hyperammonemia: effect of l-carnitine. Pediatr Neurol 1997; 16: 301-305 (Pubitemid 27329935)
18. Tein I, Xie ZW. Reversal of valproic acid-associated impairment of carnitine uptake in cultured human skin fibroblasts. Biochem Biophys Res Commun 1994; 204: 753-758 (Pubitemid 24343984)
19. Stadler DD, Bale JF, Chenard CA, Rebouche CJ. Effect of long-term valproic acid administration on the efficiency of carnitine reabsorption in humans. Metabolism 1999; 48: 74-79
20. Osuna MT, Burcet J, Ramió L, Ustrell X, Silva Y, Molins A. Encefalopatía hiperamoniémica asociada al uso de valproato sodico. Neurologia 2003; 18: 347-350 (Pubitemid 36961860)
21. Sztajnkrycer MD. A reply to 'Carnitine and role of carnitine in valproic acid toxicity'. J Toxicol Clin Toxicol 2003; 41: 901-902
22. McCall M, Bourgeois JA. Valproic acid-induced hyperammonemia: a case report. J Clin Psychopharmacol 2004; 24: 521-526 (Pubitemid 39274206)